FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
INFY Share Price Target
Infosys Ltd.
NSE: INFY | BSE: 500209 | ISIN: INE009A01021 | Sector: Information Technology
INFY Rating
- ★★
- ★★
- ★★
- ★★
- ★★
3.7/5 (30 Ratings)
INFY Share Price *
588 -14.8 (-2.46%)
* (quote may be delayed)
38 INFY share price target reports by brokerages below. See what is analyst's view on INFY share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
You can also find INFY share price target tomorrow or next week from INFY discussion forum.
INFY Share Price Forecast - Consensus
| No. of reports in last year | 38 |
| No. of analysts | 15 |
| Average Consensus Forecast | 797.39 |
| Consensus Potential | 23.60% |
INFY Share Price Target - Broker Reports - 2020
Axis Direct
30-Mar-20
Price @ Call: 636.12
Target: 720
BUY
Prabhudas Lilladher
11-Feb-20
Price @ Call: 773.6
Target: 820
BUY
We believe Simplus acquisition along with Fluido acquisition will help Infosys to further position as end-to-end Salesforce enterprise cloud solutions and services provider in US & Australia. Acquisition is valued at 3.7X EV/Sales FY20. (Fluido was acquired at 3.6X EV/Sales CY17) bit on a higher side. Simplus has a revenue base of USD 67 mn in FY20 growing at ~60% YoY, assuming 45% YoY growth in FY21E this acquisition accounts to 0.7% of Infosys revenues. Our estimates remain unchanged & continue to value Infy at 18X multiple at earnings of Rs. 45.5 (Sep-20) to arrive at a target price of Rs.820. Infosys is currently trading at 18X/16X on FY21E/22E EPS of Rs.43.6/47.7 respectively.
Karvy Stock Broking
29-Jan-20
Price @ Call: 788.06
Target: 843
BUY
While it is positive that Infy has revised the guidance, it is due to 170 bps contribution from inorganic component. Despite strong deal metrics, we are concerned about future growth due to volatility in key verticals including BFSI and Retail due to macro and structural factors. Even on margin front, we expect Infy to exit FY20E either below or at best in the mid-range of the guided band of 21%-23%. Keep in this view we continue to rate the stock a “HOLD” with a target price of Rs. 843, upside of 7%. We value the stock at 5-Yr historical average of FY21E PE of 18.5x.
Hem Securities
21-Jan-20
Price @ Call: 764.32
Target: 824
BUY
Company continued to report handsome growth in its revenue. Revenues stood at Rs. 23092 cr in quarter ended in Dec 2019 as compared to Rs 22629 cr in Sep 2019 quarter and Rs 21400 cr in the quarter ended in Dec 2018. The Company reported growth of 2.05% on QoQ basis and 7.91% on a YoY basis. The Company has shown increase in its operating profits by 2.87% on QoQ basis and 16.98% on YoY basis. PAT of the company increased by 10.63% on QoQ basis and by 23.71%on YoY basis to Rs. 4466 cr in Dec 2019 quarter.The Operating Profit margin increased by 20 basis points for Q3 on QoQ basis and by 195 basis points on YoY basis. The Net Profit margin increased by 150 basis points for Q3 on QoQ basis and by 247 basis points on YoY basis.EPS stood at Rs 10.5 per share in the relevant quarter vs Rs 9.47 per share in the last quarter and Rs 8.29 per share in Dec 2018 quarter.
Axis Direct
15-Jan-20
Price @ Call: 775.35
Target: 860
BUY
Infosys Ltd. reported strong top line growth and healthy deal wins in Q3FY20. Infosys posted revenue growth of 9.5% on YoY basis and 1.0% on QoQ basis in constant currency terms for the period of Q3FY20. Infosys reported steady deal wins (14 large deals) with a TCV of $1.8bn despite Q3 being a seasonally weak quarter. Operating margins have improved by 22 bps to 21.9% sequentially. The operating margins were in line with the guided range of 21%-23%. Infosys revised its full year revenue guidance for FY20 to 10%- 10.5% from previous 9%-10% and operating margin guidance maintained at 21%-23% for FY20. Independent audit committee issued a clean chit to the Infosys management from whistle blower complaints. Healthy deal wins, higher growth in key business verticals will put Infosys back on growth trajectory. We assign 18.3x P/E multiple to its FY22E earnings of Rs. 46.8 per share which gives a target price of Rs. 860 per share, an upside of 11%.
Sharekhan
10-Jan-20
Price @ Call: 737.07
Target: 820
BUY
Valuation – Maintain Buy with a revised PT of Rs. 820: We have tweaked our earnings estimates for FY2020E/FY2021E on account of increase in revenue growth guidance, though margins missed our estimates slightly. We introduced FY2022E numbers in this note. With continued robust TCV signings, a healthy deal pipeline and integrated offerings, we believe Infosys would comfortably deliver double-digit CC growth in FY2020E. At CMP, the stock is trading at 18x/17x of its FY2020E/FY2021E earnings estimates, which is currently at around 26% discount to TCS. As Infosys is expected to outperform TCS in terms of revenue growth and gaining market share in digital business among peers, we believe the discount to TCS would narrow down going ahead. Further a clean chit in whistleblower issue would remove overhang on the stock. Hence, we maintain our Buy rating on the stock with a revised PT of Rs. 820.
HDFC Securities
13-Jan-20
Price @ Call: 768.72
Target: 850
BUY
In-line rev/margin and a positive troika of rev guidance increase, attrition decline and Board’s clean chit on whistleblower allegations marked 3Q. Maintain BUY (top pick in tier-1 IT) with TP of Rs 850, at 18x Dec-21E EPS (unchanged est/multiple).
ICICIdirect.com
13-Jan-20
Price @ Call: 768.72
Target: 890
BUY
Highlight of the quarterly results was the clean chit given by the Audit Committee of the Board to the company in light of anonymous whistle- blower complaint. Further, healthy deal signings, digital growth and scope of margin expansion would drive the profitability. In addition, we expect valuation gap between Infosys and TCS (P/E discount of ~25% based on FY21E EPS) to narrow with improving financials. We roll over our valuations on FY22E and maintain BUY rating on the stock with a revised target price of Rs 890 (based on 18x FY22E EPS).
Motilal Oswal
13-Jan-20
Price @ Call: 738.25
Target: 870
BUY
In a cautious spending environment, we expect INFO to outperform TCS on growth (8.2% YoY v/s 6.1% YoY of TCS, FY21, CC). Our comfort was driven by INFO’s continued robustness in large deal wins and strong order backlog. In addition, as investments stabilize and back-ended benefits (e.g. productivity improvement in US onsite workforce) kick in, we foresee meaningful headroom for margin expansion (~130bp over FY20-22). As the whistleblower-related overhang is now behind and with expectations of a growth outperformance (v/s TCS), we expect slight re-rating in one-year forward P/E to ~18x, as the discount (v/s TCS) reverts to normalized levels.
Prabhudas Lilladher
13-Jan-20
Price @ Call: 738.25
Target: 820
BUY
Infosys stock price is still down 10% since the whistleblower allegations took place. Whistleblower allegation was the key overhang on the valuations. Infosys is currently trading at 17X/15.5X FY21E/FY22E multiple which is ~28% discount to TCS multiples’. With the clean chit, strong deal pipeline & margin improvement levers we expect the discount to narrow to 20%. With the modest miss on revenues in Q3 & steady headwinds of BFSI/Retail ahead, we have marginally tuned our estimates & continue to value Infy at 18X multiple at earnings of Rs. 45.5 (Sep-20) to arrive at a changed target price of Rs.820. INFY remains our top pick in tier-1 IT companies.
INFY Share Price Target - Broker Reports - 2019
Axis Direct
11-Nov-19
Price @ Call: 703.68
Target: 805
BUY
Strong revenue growth, healthy deal wins in Q2FY20: Infosys posted revenue growth of 11.4% on YoY basis and 3.3% sequential growth in constant currency terms for the period of Q2FY20 aided mainly by broad based growth across all verticals. Operating margins have improved by 120 bps to 21.7% sequentially mainly due to higher utilization, improved offshore mix and automation benefits. Infosys revised its full year revenue guidance for FY20 to 9%- 10.0% from previous 8.5%-9.5% and operating margin guidance is also maintained at 21%-23% for FY20. Healthy deal wins, higher growth in key business verticals will put Infosys back on growth trajectory.We recommend Buy with target price of Rs 805.
Sharekhan
23-Oct-19
Price @ Call: 635.96
Target: 780
BUY
Valuation – Whistleblower allegation an overhang: The stock corrected more than 15% on October 23, after the allegations broke out. Note that in earlier whistleblower allegations in 2017 the stock’s multiple was also de-rated from 20x to 13x. Hence, we believe that the recent issue is likely to loom over the stock in the near term as it would divert management attention and affect performance. Also, any possible senior-level exits owing to the issue would drag down the stock and restrict any re-rating of multiples until clarity emerges. Given its relative outperformance among large peers, we maintain our Buy rating on the stock with a revised price target (PT) of Rs. 780.
Prabhudas Lilladher
7-Nov-19
Price @ Call: 718.53
Target: 819
BUY
We upgrade Infosys to BUY as it is trading at an attractive valuation of 16.5x Mar-21 earnings multiple which is 30% discount to TCS & also offering a dividend yield of 3.53%. We value Infosys on Sep-21 earnings at 18x multiple & arrive at unchanged target price of Rs.819. INFY is trading at 19.3x/16.6X/15x FY20E/21E/22E earnings at an EPS of Rs.37.2/43.2/47.8 respectively.
Axis Direct
23-Oct-19
Price @ Call: 635.96
Target: 730
HOLD
Infosys Ltd. reported strong growth in top line and healthy deal wins for the period of Q2FY20. Infosys posted revenue growth of 11.4% on YoY basis and 3.3% sequential growth in constant currency terms for the period of Q2FY20. Deal wins came in strong with TCV of $2.8bn; it remained healthy for yet another quarter. Operating margins have improved by 120 bps to 21.7% sequentially mainly due to higher utilization, improved offshore mix and automation benefits. Infosys revised its full year revenue guidance for FY20 to 9%- 10.0% from previous 8.5%-9.5% and operating margin guidance is also maintained at 21%-23% for FY20. Healthy deal wins, higher growth in key business verticals will put Infosys back on growth trajectory. We assign 16.8x P/E multiple to its FY21E earnings of Rs. 43.4 per share which gives a target price of Rs. 730 per share, an upside of 12%.
Reliance Securities
15-Oct-19
Price @ Call: 769.72
Target: 875
HOLD
Sharekhan
11-Oct-19
Price @ Call: 806.65
Target: 880
BUY
Motilal Oswal
12-Oct-19
Price @ Call: 806.65
Target: 930
BUY
We upgrade our FY20 earnings estimate by 5%, largely to factor in better margin expectations.
Over 1HFY20, INFO had outperformed TCS on growth. However, over the medium term, the performance of these companies is likely to converge.We expect a CAGR (FY19-21) of 9.3% in CC revenue and 11.5% in EPS. The stock price discounts FY20/21 earnings by 21.5/18.5x—10% discount to TCS (on FY21 multiples). Our price target of INR930 discounts forward earnings by 19x, implying an upside of 15%. Maintain Buy.
Over 1HFY20, INFO had outperformed TCS on growth. However, over the medium term, the performance of these companies is likely to converge.We expect a CAGR (FY19-21) of 9.3% in CC revenue and 11.5% in EPS. The stock price discounts FY20/21 earnings by 21.5/18.5x—10% discount to TCS (on FY21 multiples). Our price target of INR930 discounts forward earnings by 19x, implying an upside of 15%. Maintain Buy.
ICICIdirect.com
15-Oct-19
Price @ Call: 785.65
Target: 855
HOLD
In line revenue & better-than-expected margins, accelerating deal TCV, digital growth and scope of margin expansion are key positives. Though we expect revenue growth to moderately surpass the upper guided band, the recent run up in the stock and fully priced valuations prompt us to maintain our HOLD rating with a revised target price of | 855 (based on 19x FY21E EPS).
Nirmal Bang
14-Oct-19
Price @ Call: 815.7
Target: 625
SELL
We stick to our view that Infosys could nose ahead of TCS in FY20 in revenue growth (by ~100-150bps), whilet was behind by ~240bps in FY19. Post 2QFY20, we broadly hold on to our estimates (see Exhibit 2) for FY20/FY21/FY22. EPS is higher on higher other income. We maintain our Sell rating on Infosys with a September 2021 target price (TP) of Rs625 (at a target P/E of 14.9X FY21E EPS, 10% discount to TCS’ target P/E).
Prabhudas Lilladher
13-Oct-19
Price @ Call: 806.65
Target: 819
HOLD
We find it difficult for multiple to re-rate from here as there is macro slowdown & demand environment is moderating. We have fine-tuned our estimates & introduced FY22 estimates. We now value Infosys on Sep-21 earnings (earlier Mar-21 earnings) at 18x multiple (earlier 18.5x) & arrive at a changed target price of Rs.819(earlier Rs.780). INFY is trading at 22.9x/18.8X/17x FY20E/21E/22E earnings at an EPS of Rs.37.2/43.2/47.8 respectively.
Axis Direct
17-Jul-19
Price @ Call: 784.95
Target: 860
BUY
Q1FY20: Strong revenue growth, Healthy deal wins Infosys Ltd. reported strong growth in top line and healthy deal wins for the period of Q1FY20. Infosys posted revenue growth of 10.6% on YoY basis and 2.3% sequential growth in constant currency terms for the period of Q1FY20. Deal wins came in strong with TCV of $2.7bn; it remained healthy for yet another quarter. However operating margins have declined by 93 bps to 20.5% sequentially. Infosys revised its full year revenue guidance for FY20 to 8.5%- 10.0% from previous 7.5%-9.5% and operating margin guidance is also maintained at 21%-23% for FY20. Healthy deal wins, higher growth in key business verticals will put Infosys back on growth trajectory. We assign 20x P/E multiple to its FY21E earnings of Rs. 43.0 per share which gives a target price of Rs. 860 per share, an upside of 10%.
ICICIdirect.com
15-Jul-19
Price @ Call: 727.1
Target: 845
HOLD
Valuation & Outlook: Healthy quarter performance, digital growth, visibility from deal pipeline and improving margin trajectory lead us to maintain our positive stance on Infosys. Further, we believe this would narrow the revenue and margin gap with TCS. However, recent run up in stock prompt us to downgrade the stock from Buy to HOLD with a target price of 845 (based on 19x FY21E EPS).
Motilal Oswal
15-Jul-19
Price @ Call: 727.1
Target: 840
BUY
Our earnings estimate for FY20 is up marginally by 1.6% due to the small beat across the board. More significant for valuations was the capital allocation policy change, which will enhance its pre-tax payout yields. We note the contrast in INFO’s 1QFY20 performance to that of TCS – where near-term revenue visibility remained suspect and the growth performance was lopsided in favor of two verticals. Given this – and with payouts converged too – the case for narrowing of the valuation gap gets stronger. We expect a CAGR (FY19-21) of 10.5% in CC revenue and 12.4% in EPS. The stock price discounts FY20/21 earnings by 19.4/16.6—28% discount to TCS. Our price target of INR840 discounts forward earnings by 19x, implying an upside of 15%. Maintain Buy.
Nirmal Bang
15-Jul-19
Price @ Call: 727.1
Target: 596
SELL
We maintain our Sell rating on Infosys with a March 2020 target price (TP) of Rs596 (at a target P/E of 14.9x FY21E EPS, 10% discount to TCS’ target P/E). We retainthe 10% discount to TCS. While revenue growth of Infosys is likely to be a tad faster than TCS in FY20 and possibly in FY21 too, TCS will have better margins and RoIC. We reiterate our underweight call on the IT services sector as we forecast a 0% industry growth in FY21 (see sector view on the next page). But within this stance we prefer TCS followed by Infosys and HCL Technologies over the next 12-24 months.
Dolat Capital
24-May-19
Price @ Call: 701.25
Target: 700
SELL
Axis Direct
23-Apr-19
Price @ Call: 720.6
Target: 807
BUY
Infosys Ltd. reported strong growth in top line and healthy deal wins for the period of Q4FY19. Infosys posted revenue growth of 9.1% on YoY basis and 2.4% sequential growth in constant currency terms for the period of Q4FY19. Deal wins came in strong with TCV of $1.6bn; it remained healthy for yet another quarter. In the current financial year total deals TCV stands at $6.2bn. However operating margins have declined by 113 bps to 22.5% sequentially. Infosys revised its full year revenue guidance for FY20 to 7.5%- 9.5% from previous 8.5%-10.5% and operating margin guidance is also lowered at 21%-23% for FY20. The board has recommended a buyback of Rs 8,260 cr at a maximum buyback price of Rs 800per share.
Healthy deal wins, higher growth in key business verticals will put Infosys back on growth trajectory. We assign 18.6x P/E multiple to its FY21E earnings of Rs. 43.4 per share which gives a target price of Rs. 807 per share, an upside of 13%.
Healthy deal wins, higher growth in key business verticals will put Infosys back on growth trajectory. We assign 18.6x P/E multiple to its FY21E earnings of Rs. 43.4 per share which gives a target price of Rs. 807 per share, an upside of 13%.
Reliance Securities
18-Apr-19
Price @ Call: 723.85
Target: 780
HOLD
Even as revenue growth is encouraging, we are nonplussed by Infosys’ margin guidance. FY20E margin will hit its lowest-ever level, and is likely to be ~400bps below the 5-years ago level and >800bps lower than 10-years ago level. While we have consistently maintained our view of ‘good revenue growth but at a cost’, lower-than-expected outlook comes as a negative surprise. Persistently higher attrition rate could also eat away profitability on higher employee retention cost. The stock is up 27% over the past year, and margin challenges are likely to lead to EPS CAGR of <10% over FY19-FY21E. At CMP, the stock trades at >17X FY21E EPS. We downgrade our recommendation on the stock to HOLD from BUY with a revised Target Price of Rs780 (from Rs840 earlier). Cash return in the form of buy-back could prevent the stock from declining steeply (>80% payout in FY19, RoE flattish despite steep margin decline).
KRChoksey
17-Apr-19
Price @ Call: 722.75
Target: 761
HOLD
We expect the company to generate a topline growth of 9.0%/8.2% in FY20E/FY21E owing to the strong digital business growth supported by a revival in global IT spending (expected to increase 3.5%/2.8% in CY20E/21E). We expect contribution from the new business (deal wins with TCV of USD 1.6bn in 4QFY19) and Stater acquisition to drive top line growth. Partially offsetting this growth will be a weakness in its core business revenue. On the margin front, we expect investments towards scaling digital offerings and increased localization to continue to negatively impact the operating margin in FY20E. However, we expect the company’s buy back plan (~80% allocated capital left unutilized) to act as a support for the stock price. Infosys is currently trading at a P/E multiple of 19.5x/18.5x on FY20E/FY21E earnings. We conservatively apply a P/E multiple of 19.8x to the FY20 estimated EPS of INR 38.4 to arrive at a revised target price of INR 761 per share, an upside of 2% over the CMP. Accordingly, we reiterate our HOLD rating.
Nalanda Securities
16-Apr-19
Price @ Call: 726.65
Target: 735
HOLD
Infosys’ FY2020E revenue growth guidance of 7.5-9.5% is a touch lighter than expected. This includes contribution from Stater acquisition (the mortgage processing arm of ABN AMRO) though the management did not quantify the magnitude. The company reported that clients are monitoring spends closely and could curtail spends in the event of a slowdown. While growth in large deal TCV has been decent, Infosys’ modest organic guidance of 6.5-8.5% indicates pressure/contraction in renewals. Further the company faces headwinds from wage hikes in H1FY20E and increased levels of attrition.
Arihant Capital Markets
16-Apr-19
Price @ Call: 726.65
Target: 849
ACCUMULATE
Infosys management has guided for CC revenue growth of 7.5-9.5% for FY20E, which is slightly lower than our estimate of 8-10%, though the company kept its EBIT margin guidance at 21-23% for FY20E, which is in line with our estimate. With robust growth in its digital business and Q4FY19 being the second successive quarter of over US$ 1.5 billion large deal TCV, management is positive about the strong demand pipeline in the system. At CMP of Rs 748, Infosys is trading at a P/E of 18.9x its FY20E earnings. We maintain our Accumulate rating on the stock with a revised target price of Rs 849 (21.5x FY20E EPS), an upside of 13.5%.
Nirmal Bang
15-Apr-19
Price @ Call: 747.85
Target: 601
SELL
We retain our Sell rating on Infosys with a March 2020 target price of Rs601 (at a target P/E of 14.9x FY21E EPS, 10% discount to that of TCS’ target P/E). We had reduced the discount to TCS from 20% to 10% expecting reduction in growth gap. The margin performance does raise issues as to whether such a discount reduction could sustain. While revenue growth of Infosys is likely to be a tad faster than that of TCS in FY20, TCS will have better margins and RoIC. We believe the ongoing share buyback – a substantial part of which is yet incomplete – will cushion any big cuts on the stock. We believe the CEO, Mr. Salil Parekh, had a fortuitous start because of a very good macro in most of 2018 and to everyone’s surprise there was ample revenue acceleration in Year 1 itself. We believe he is going to be tested in FY21 in what would be a more hostile operating environment
Dolat Capital
15-Apr-19
Price @ Call: 747.85
Target: 700
SELL
We believe that higher sub-contracting cost, higher attrition, implied investment and localisation in the medium term will lead to margin pressure in FY20 for INFY. We expect INFY to report margins towards the mid-point of its guidance in FY20. We downgrade our earnings estimates by 12%/11.5% for FY20/FY21, primarily because of rupee appreciation and margin headwinds going ahead. We change our rupee assumption to Rs 70 for FY20/FY21 as compared to Rs 74/ Rs 76 earlier which led to major downgrade in our earnings estimate. We downgrade INFY to SELL with revised TP of Rs 700 ( Rs 840 earlier) based on 17x one-year fwd. PER.
Sharekhan
15-Apr-19
Price @ Call: 747.85
Target: 840
BUY
Valuation: Maintain Buy with a PT of Rs. 840: We have tweaked our earnings estimates for FY2020E/FY2021E, factoring in lower-than- expected margin guidance for FY2020E and change in USD/INR rate. At CMP, the stock is trading at 19x/17x its FY2020/FY2021E earnings estimates. With robust TCV signings and improving business visibility, we believe that Infosys would gradually catch up in revenue growth with TCS in FY2020E and in-turn would narrow the valuation gap with TCS going forward. Thus, we maintain our Buy rating on the stock with an unchanged price target (PT) of Rs. 840.
HDFC Securities
15-Apr-19
Price @ Call: 747.85
Target: 755
NEUTRAL
We downgrade Infosys to NEUTRAL (from BUY) post its inline revenues in 4QFY19. The growth challenges and margin trajectory compels us to cut estimates by ~5%. Our TP falls to Rs 755 (Rs 805 earlier) at 18x FY21E EPS.
ICICIdirect.com
15-Apr-19
Price @ Call: 747.85
Target: 805
BUY
Digital being a multiyear opportunity and relatively less impacted by macro slowdown, will be key growth driver for Infosys. Further, we believe healthy deal wins will enable the company to narrow the revenue and margin gap with TCS. Hence, we maintain BUY rating on the stock with a target price of | 805 (based on 18x FY21E EPS, which is 15% discount to TCS).
Motilal Oswal
15-Apr-19
Price @ Call: 747.85
Target: 860
BUY
While a weak exit in terms of margins and a further cut in the guidance naturally raise concerns about the lack of profitable growth, INFO cited that it is the back-ended investments in FY19 that are dragging the FY20 outlook, and that the focus hereon will be on driving efficiency levers. We expect the company to reverse its sequential margin trajectory after 1QFY20 (impacted by wage hikes). Our FY20/21 EBIT margin estimates are 22.2%/22.6%, 40bp/30bp lower. Our USD revenue growth estimate stands at 10% for both the years going forward, and absolute revenue estimate is ~0.5% lower. With a robust performance on deal wins, INFO’s revenue momentum is catching up with leading peers such as TCS, and the recent disappointment on margins should see its worst in 1QFY20, before reversing. Our price target of INR860 discounts forward EPS by 19x (5% discount to TCS). Maintain Buy.
Investec Securities
15-Apr-19
Price @ Call: 747.85
Target: 750
HOLD
Prabhudas Lilladher
14-Apr-19
Price @ Call: 746.95
Target: 782
ACCUMULATE
Infosys reported inline Q4FY19 revenue performance but sharp miss on margins due to large deal impact & investments on people. Management guided a lower than expected revenue growth for FY20E due to uncertain macro environment. EBIT margin guidance was lowered to 21%-23% from 22- 24%, the lower margin guidance was due to need of investments ahead for demand acceleration. We don’t see guidance retuning back to beat-and-raise strategy as we believe macro environment vulnerability had led to lower revenue guidance. Revenue growth in this quarter was largely led by communication vertical, BFSI & retail both disappointed. If growth acceleration doesn’t happen in BFSI in next 2 quarters, that will lead to our multiple de-rating for Infosys. We are confident about Mr. Salil Parekh’s leadership & execution but we are cautious about margin expansion due to headwinds such as higher compensation, continued investments & impact on margin due to transition & ramp-up of recently won deals. We have cut our EPS estimates by 2.7% & 3.4% of FY20E/FY21E to factor lower than expected guidance & reduced margin assumption (-70bps: FY20E, -92bps: FY21E). Our revised TP stands at Rs.782 (earlier: Rs.808) valued at 18.5x Mar-21 multiple. We expect share buyback (max price of Rs.800) to cushion earnings downgrade in near term. Maintain Accumulate.
Axis Direct
18-Mar-19
Price @ Call: 711.5
Target: 810
BUY
Robust business structure, healthy deal pipeline and revitalization of key business segment makes Infosys a safer bet to invest in. Rising demand across geographies and across different verticals helps Infosys to attain higher growth momentum. We have a BUY with a target of Rs. 810
Motilal Oswal
26-Feb-19
Price @ Call: 748
Target: 865
BUY
Traditionally, revenue growth has been a key lever for margin expansion in the industry. This was due to disproportionately higher fresher additions to fuel growth, which brought down the overall cost of delivery. In the recent past, onsite centricity, healthy lateral mix, and greater use of sub- contractors are all accompaniments of growth, defying revenue growth as a lever for profitability. But sustained demand should allow the industry to either (1) pass on the higher cost to clients, or (2) eventually reap the fruits of investing in onsite talent development. We estimate margin pressure for INFO to bottom out in FY20 between 22.5 - 23%. Our price target of INR865 discounts forward earnings by 19x, a 10% discount to TCS’ 1-year forward multiple. Maintain Buy.
Axis Direct
2-Feb-19
Price @ Call: 753.6
Target: 810
BUY
Geojit Financial Services
28-Jan-19
Price @ Call: 730.2
Target: 802
HOLD
ICICIdirect.com
15-Jan-19
Price @ Call: 700.9
Target: 780
BUY
Arihant Capital Markets
15-Jan-19
Price @ Call: 700.9
Target: 800
ACCUMULATE
Edelweiss
15-Jan-19
Price @ Call: 700.9
Target: 880
BUY
Dolat Capital
15-Jan-19
Price @ Call: 700.9
Target: 840
BUY
Indiabulls Ventures
15-Jan-19
Price @ Call: 700.9
Target: 776
BUY
Nirmal Bang
14-Jan-19
Price @ Call: 683.7
Target: 603
SELL
Sharekhan
14-Jan-19
Price @ Call: 683.7
Target: 840
BUY
Antique Stock Broking
14-Jan-19
Price @ Call: 683.7
Target: 810
BUY
Motilal Oswal
11-Jan-19
Price @ Call: 678.83
Target: 800
BUY
Investec Securities
14-Jan-19
Price @ Call: 683.7
Target: 784
BUY
Phillip Capital
14-Jan-19
Price @ Call: 683.7
Target: 800
BUY
HDFC Securities
12-Jan-19
Price @ Call: 678.83
Target: 800
BUY
Prabhudas Lilladher
14-Jan-19
Price @ Call: 683.7
Target: 810
BUY
INFY Share Price Target - Broker Reports - 2018
HDFC Securities
17-Oct-18
Price @ Call: 710.96
Target: 800
BUY
Nirmal Bang
18-Oct-18
Price @ Call: 710.96
Target: 756
ACCUMULATE
Motilal Oswal
17-Oct-18
Price @ Call: 710.96
Target: 800
BUY
Edelweiss
17-Oct-18
Price @ Call: 696.4
Target: 880
BUY
Prabhudas Lilladher
16-Oct-18
Price @ Call: 699.1
Target: 790
BUY
Axis Direct
8-Oct-18
Price @ Call: 716.97
Target: 794
BUY
Motilal Oswal
8-Oct-18
Price @ Call: 716.97
Target: 830
BUY
Sharekhan
17-Sep-18
Price @ Call: 731.11
Target: 840
BUY
Dolat Capital
17-Jul-18
Price @ Call: 666.53
Target: 750
BUY
HDFC Securities
16-Jul-18
Price @ Call: 1309.1
Target: 1415
BUY
JM Financial
13-Jul-18
Price @ Call: 1310.36
Target: 1420
BUY
ICICIdirect.com
16-Jul-18
Price @ Call: 1309.1
Target: 1410
HOLD
Arihant Capital Markets
16-Jul-18
Price @ Call: 1309.1
Target: 1411
HOLD
Sharekhan
13-Jul-18
Price @ Call: 655.18
Target: 725
BUY
Investec Securities
16-Jul-18
Price @ Call: 654.55
Target: 720
BUY
Prabhudas Lilladher
13-Jul-18
Price @ Call: 1310.36
Target: 1430
BUY
Motilal Oswal
13-Jul-18
Price @ Call: 655.18
Target: 775
BUY
Sharekhan
8-Jun-18
Price @ Call: 1250.8
Target: 1420
BUY
Motilal Oswal
29-May-18
Price @ Call: 607.55
Target: 700
BUY
KRChoksey
16-Apr-18
Price @ Call: 1124.89
Target: 1184
HOLD
Reliance Securities
16-Apr-18
Price @ Call: 1124.89
Target: 1290
BUY
Kotak Securities
16-Apr-18
Price @ Call: 1124.89
Target: 1250
ADD
HDFC Securities
16-Apr-18
Price @ Call: 1124.89
Target: 1300
BUY
Axis Direct
16-Apr-18
Price @ Call: 1124.89
Target: 1340
ADD
Edelweiss
16-Apr-18
Price @ Call: 1169
Target: 1419
BUY
Motilal Oswal
16-Apr-18
Price @ Call: 1169
Target: 1330
BUY
Prabhudas Lilladher
13-Apr-18
Price @ Call: 1170.75
Target: 1220
BUY
Axis Direct
28-Mar-18
Price @ Call: 1140.27
Target: 1345
BUY
JM Financial
22-Mar-18
Price @ Call: 1168.6
Target: 1300
BUY
Edelweiss
5-Mar-18
Price @ Call: 1160.25
Target: 1280
BUY
Kotak Securities
28-Feb-18
Price @ Call: 1148.3
Target: 1250
ADD
HDFC Securities
21-Feb-18
Price @ Call: 1147.22
Target: 1325
BUY
Axis Direct
22-Jan-18
Price @ Call: 571.63
Target: 672.5
BUY
JM Financial
15-Jan-18
Price @ Call: 540.24
Target: 575
BUY
Reliance Securities
16-Jan-18
Price @ Call: 540.2
Target: 620
BUY
Prabhudas Lilladher
15-Jan-18
Price @ Call: 539.2
Target: 610
BUY
Arihant Capital Markets
15-Jan-18
Price @ Call: 539.2
Target: 619
BUY
Edelweiss
15-Jan-18
Price @ Call: 539.2
Target: 632.5
BUY
Motilal Oswal
12-Jan-18
Price @ Call: 538.23
Target: 625
BUY
Motilal Oswal
9-Jan-18
Price @ Call: 518.73
Target: 600
BUY
INFY Share Price Target - Broker Reports - 2017
HDFC Securities
26-Dec-17
Price @ Call: 519.2
Target: 629
BUY
Axis Direct
7-Dec-17
Price @ Call: 495.2
Target: 560
BUY
Nirmal Bang
4-Dec-17
Price @ Call: 492.97
Target: 436.5
SELL
ICICIdirect.com
4-Dec-17
Price @ Call: 479.25
Target: 510
HOLD
Motilal Oswal
4-Dec-17
Price @ Call: 479.25
Target: 550
BUY
Axis Direct
31-Oct-17
Price @ Call: 472.33
Target: 600
BUY
Sharekhan
26-Oct-17
Price @ Call: 467.7
Target: 500
HOLD
Motilal Oswal
25-Oct-17
Price @ Call: 467.67
Target: 550
BUY
HDFC Securities
25-Oct-17
Price @ Call: 463.38
Target: 500
NEUTRAL
Prabhudas Lilladher
25-Oct-17
Price @ Call: 463.38
Target: 535
ACCUMULATE
Edelweiss
25-Oct-17
Price @ Call: 463.38
Target: 505
HOLD
Axis Direct
1-Sep-17
Price @ Call: 457.65
Target: 569
BUY
Edelweiss
28-Aug-17
Price @ Call: 456.25
Target: 505
HOLD
ICICIdirect.com
28-Aug-17
Price @ Call: 456.25
Target: 487.5
HOLD
Motilal Oswal
28-Aug-17
Price @ Call: 456.25
Target: 515
BUY
Nirmal Bang
28-Aug-17
Price @ Call: 456.25
Target: 418
SELL
Phillip Capital
28-Aug-17
Price @ Call: 456.25
Target: 530
BUY
HDFC Securities
22-Aug-17
Price @ Call: 436.75
Target: 497.5
NEUTRAL
Reliance Securities
22-Aug-17
Price @ Call: 436.75
Target: 540
BUY
Motilal Oswal
22-Aug-17
Price @ Call: 436.75
Target: 515
BUY
Edelweiss
21-Aug-17
Price @ Call: 461.55
Target: 505
HOLD
Axis Direct
21-Aug-17
Price @ Call: 461.55
Target: 498
HOLD
ICICIdirect.com
21-Aug-17
Price @ Call: 461.55
Target: 487.5
HOLD
Edelweiss
18-Aug-17
Price @ Call: 510.58
Target: 577.5
BUY
Angel Broking
17-Jul-17
Price @ Call: 486
Target: 589.5
BUY
KRChoksey
14-Jul-17
Price @ Call: 488.5
Target: 579
BUY
Motilal Oswal
14-Jul-17
Price @ Call: 486
Target: 600
BUY
Nirmal Bang
17-Jul-17
Price @ Call: 486
Target: 423
SELL
ICICIdirect.com
17-Jul-17
Price @ Call: 486.03
Target: 520
HOLD
Shahina Mukadam
12-Jul-17
Price @ Call: 487.9
Target: 525
HOLD
Reliance Securities
21-Jun-17
Price @ Call: 470.45
Target: 520
BUY
Edelweiss
16-Jun-17
Price @ Call: 476
Target: 586.5
BUY
Axis Direct
19-Apr-17
Price @ Call: 931
Target: 1092
BUY
Geojit Financial Services
19-Apr-17
Price @ Call: 922
Target: 986
HOLD
Arihant Capital Markets
13-Apr-17
Price @ Call: 931
Target: 1022
HOLD
Motilal Oswal
17-Apr-17
Price @ Call: 933
Target: 1200
BUY
KRChoksey
13-Apr-17
Price @ Call: 931
Target: 1060
ACCUMULATE
ICICIdirect.com
13-Apr-17
Price @ Call: 930
Target: 1060
BUY
India Nivesh
8-Mar-17
Price @ Call: 1020
Target: 1130
BUY
Arihant Capital Markets
13-Jan-17
Price @ Call: 972
Target: 1110
ACCUMULATE
Motilal Oswal
13-Jan-17
Price @ Call: 975
Target: 1250
BUY
ICICIdirect.com
13-Jan-17
Price @ Call: 975
Target: 1110
BUY
INFY Share Price Target - Broker Reports - 2016
Axis Direct
18-Apr-16
Price @ Call: 1172
Target: 1500
BUY
Religare
18-Apr-16
Price @ Call: 1236.45
Target: 1330
BUY
Nirmal Bang
18-Apr-16
Price @ Call: 1236.45
Target: 1010
SELL
Kotak Securities
18-Apr-16
Price @ Call: 1237.5
Target: 1425
BUY
Centrum
17-Oct-16
Price @ Call: 1027
Target: 1210
BUY
Geojit Financial Services
18-Oct-16
Price @ Call: 1022
Target: 1151
BUY
Axis Direct
17-Oct-16
Price @ Call: 1028
Target: 1075
HOLD
KRChoksey
18-Oct-16
Price @ Call: 1035.07
Target: 1123
BUY
Cholamandalam Securities
17-Oct-16
Price @ Call: 1027.4
Target: 1196
BUY
Religare
14-Oct-16
Price @ Call: 1027.15
Target: 1150
BUY
Arihant Capital Markets
14-Oct-16
Price @ Call: 1035
Target: 1140
HOLD
Religare
29-Aug-16
Price @ Call: 1020.25
Target: 1200
BUY
ICICIdirect.com
30-Aug-16
Price @ Call: 1021
Target: 1290
BUY
Prabhudas Lilladher
29-Aug-16
Price @ Call: 1037
Target: 1400
BUY
Motilal Oswal
17-Aug-16
Price @ Call: 1036
Target: 1300
BUY
Edelweiss
21-Jul-16
Price @ Call: 1079
Target: 1370
BUY
Angel Broking
27-Jun-16
Price @ Call: 1165.1
Target: 1374
BUY
Prabhudas Lilladher
20-Jun-16
Price @ Call: 1202.31
Target: 1540
BUY
Kotak Securities
14-Jun-16
Price @ Call: 1182.55
Target: 1425
BUY
- keyboard_arrow_down
INFY Peer Stocks - Share Price Targets
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.